2012
DOI: 10.1152/ajpgi.00244.2011
|View full text |Cite
|
Sign up to set email alerts
|

BMP signaling in rats with TNBS-induced colitis following BMP7 therapy

Abstract: yond stimulating bone formation, bone morphogenetic proteins (BMPs) are important in development, inflammation, and malignancy of the gut. We have previously shown that BMP7 has a regenerative, anti-inflammatory, and antiproliferative effect on experimental inflammatory bowel disease (IBD) in rats. To further investigate the BMP signaling pathway we monitored the effect of BMP7 therapy on the BMP signaling components in the rat colon during different stages of experimentally induced colitis by 2,4,6-trinitrobe… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
23
0

Year Published

2012
2012
2018
2018

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 23 publications
(25 citation statements)
references
References 77 publications
(98 reference statements)
2
23
0
Order By: Relevance
“…However, exogenous BMP-7 application resulted in a significant increase in BMPR2 expression on monocytes and M2 macrophages suggesting an increase in BMP-7 signal transduction activity. Several studies have supplied supporting evidence to the current findings indicating an upregulation of BMPR2 expression at 2 days following BMP-7 administration in various models including TNBS-induced colitis [5], [15]. Of note, following treatment with follistatin, an inhibitor of BMP-7 signal transduction, significant upregulation of BMPR2 on monocytes and M2 macrophages was abolished suggesting a direct relation between BMP-7 signaling and upregulation of BMPR2.…”
Section: Discussionsupporting
confidence: 82%
“…However, exogenous BMP-7 application resulted in a significant increase in BMPR2 expression on monocytes and M2 macrophages suggesting an increase in BMP-7 signal transduction activity. Several studies have supplied supporting evidence to the current findings indicating an upregulation of BMPR2 expression at 2 days following BMP-7 administration in various models including TNBS-induced colitis [5], [15]. Of note, following treatment with follistatin, an inhibitor of BMP-7 signal transduction, significant upregulation of BMPR2 on monocytes and M2 macrophages was abolished suggesting a direct relation between BMP-7 signaling and upregulation of BMPR2.…”
Section: Discussionsupporting
confidence: 82%
“…Therefore, new types of therapies are needed that can prevent disease or relapse. Several promising options are currently under evaluation in clinical trials and in different animal models of experimental colitis [1,9,12,13]. IBD-like symptoms can be chemically-induced in several animal models, but the mouse model offers several advantages including multiple methods for inducing experimental colitis, a wide array of biochemical and immunological reagents, a well-defined immune system, and the availability of numerous signaling molecule-deficient mice to evaluate treatment specificity [11,14-16].…”
Section: Introductionmentioning
confidence: 99%
“…Similarly, BMP-7 has been shown to ameliorate the severity of colonic inflammation and to accelerate the healing of colitis in rats exposed to trinitrobenzene sulfonic acid, a well-established inducer of experimental colitis in rodents. 19,20 Finally, transgenic expression of BMP-4 in the skin of mice treated with both the carcinogen N-methyl-N’-nitrosoguanidine and the tumor promoter 12-O-teradecanoylphorbol-13-acetate leads to a marked decrease in the degree of cellular hyperproliferation and inflammation induced by these agents. 24 …”
mentioning
confidence: 99%